	How representative are responders to the english cancer patient experience survey of english breast cancer patients? A cohort study using linked national cancer patient experience survey and cancer registry data. BMJ Open Blacker S, Boyle J, Wang L, Withrow DR, Delon C, Medina J, Horgan K, Dodwell D, Verrill M, Lemanska A, Frampton AE, Cromwell DA. PMID: 42855234 [PubMed - in process]
	Circular RNAs in Breast Cancer Immunometabolism: Mechanisms of Immune Regulation and Metabolic Reprogramming. Crit Rev Oncol Hematol Jing H, Jian J, Xing C, Luo H. PMID: 42854996 [PubMed - as supplied by publisher]
	Preclinical Evidence for Mifepristone in Breast Cancer: A Systematic Review and Meta-analysis of Animal Studies. Eur J Pharmacol Li A, Zhang R, Li Y, Fang M, Li C, Yang H, Zhong Z, Zheng C. PMID: 42854814 [PubMed - as supplied by publisher]
	Invasive interval breast cancer rates after digital breast tomosynthesis plus synthesised mammography versus digital mammography screening (TOSYMA): 24-month follow-up of the multicentre, open-label, randomised, controlled, superiority trial. Lancet Oncol Weigel S, Hense HW, Weyer-Elberich V, Czwoydzinski J, Decker T, Kajüter H, Oesterling F, Heilmann J, Stang A, Kieschke J, Wienbeck S, Stephan O, Baier S, Krischke M, Sommer A, Gerß J, Heindel W, TOSYMA Screening Trial Study Group. PMID: 42854706 [PubMed - as supplied by publisher]
	Overview of breast cancer screening in Spain and its impact on mortality: An ecological study examining temporal trends (2000-2023). Med Clin (Barc) Gisbert-Canet M, Pereyra-Zamora P, Sánchez-Heras AB, Tamayo-Fonseca N, Casillas-Clot J, Nolasco A. PMID: 42854585 [PubMed - as supplied by publisher]
	Temperature-responsive PDDNFs@QDs integrating simplified isolation for efficient tumor-derived small extracellular vesicles analysis enables breast cancer diagnosis and subtyping. Biosens Bioelectron Meng X, Zhang Z, Jiang P, Qiu B, Chen J, Chen P. PMID: 42854434 [PubMed - as supplied by publisher]
	Advancing therapies for HER2-positive metastatic breast cancer: Navigating a wealth of treatment options. Cancer Treat Rev Palleschi M, Viansone A, Merloni F, Gianni C, Farolfi A, Miserocchi G, Mariotti M, Di Menna G, Serra O, Casadei C, Sabbioni S, Carlini A, Montanari D, Sirico M, Mannozzi F, Tegas M, Cecconetto L, Sarti S, Musolino A. PMID: 42854349 [PubMed - as supplied by publisher]
	Accessibility and Decision-Supportive Quality of Benign Breast Disease Articles on Chinese Hospital WeChat Public Accounts: Nationwide Cross-Sectional Study. JMIR Med Inform Li J, He C, Wang S, Ke L, Yu H, Wei X, Lei C, Hu D, Zhang Z, Zhou W, Li M, Wu W, Xu W, Bai J, Shi Q. PMID: 42854188 [PubMed - indexed for MEDLINE]
	Assessment of Adverse Drug Reaction, Medication Adherence and Quality ofÂ Life in Breast Cancer Patients: A Prospective Observational Study. Cancer Invest Ali S MA, B H, K S, C S, B T, M V. PMID: 42853970 [PubMed - as supplied by publisher]
	Patient overlap, cohort-relative scaling, and biological context in cross-cohort evaluation of a mitochondrial proteostasis-associated score in triple-negative breast cancer. PLoS One Weng X, Tang Y, Wang C, Huang Z, Huang X, Wang J. PMID: 42853826 [PubMed - indexed for MEDLINE]
	Deep Residual Learning for Iodine Estimation in Digital Breast Tomosynthesis. IEEE Trans Biomed Eng Nassi M, Coito L, Michielsen K, Sechopoulos I. PMID: 42853757 [PubMed - as supplied by publisher]
	Impact of COVID-19 on breast cancer screening: time series analysis of pre-pandemic, pandemic and post-pandemic periods. Cent Eur J Public Health Özyurt GM, Zirek S, Kolukisa D, Yüksel C, Keskin M. PMID: 42853051 [PubMed - indexed for MEDLINE]
	Management, Upgrade Rates, and Radiologic Surveillance of Screen-Detected High-Risk Breast Lesions. Radiol Imaging Cancer van der Veer EL, Bluekens AMJ, Coolen AMP, Vreuls W, Voogd AC, Duijm LEM. PMID: 42853044 [PubMed - indexed for MEDLINE]
	AI-driven multi-omics integration in breast cancer: clinical applications, immunotherapy prediction, and translational challenges. Front Mol Biosci Wang ZY, Liu N, Chen MB. PMID: 42852086 [PubMed]
	CPT1A as a metabolic gatekeeper linking fatty acid oxidation, ferroptosis resistance, and breast cancer stemness. Front Oncol Zeng F, Chen X, Long K, Yu B, Cai Y, Cai Y, Liu C. PMID: 42852059 [PubMed]
	Sentinel Lymph Node Positivity by Tumour Grade in Older Women With Breast Cancer: A Cross-Verified Retrospective Cohort Study. Cureus Mady R, Mady O, Nazim M, Boland G, Saidan Z. PMID: 42851650 [PubMed]
	A preoperative nomogram incorporating semantic MRI features for predicting breast cancer recurrence: a propensity score-matched cohort study. Front Oncol Zhang C, Xiong Y, Zhu C, Wen S, Bu J. PMID: 42851497 [PubMed]
	Efficacy and safety of immune checkpoint inhibitors plus chemotherapy in early-stage triple-negative breast cancer: a systematic review and meta-analysis. Front Oncol Li JL, Wu PT, Song JS, Yang HW. PMID: 42851451 [PubMed]
	Profiles of research waste in randomized clinical trials comparing de-escalation and escalation strategies for breast cancer treatment. Front Oncol Tang YH, Lin WJ, Li ZB, Guo JJ, Mao HH. PMID: 42851370 [PubMed]
	The translational chasm in machine learning for triple-negative breast cancer: a quantitative landscape assessment. Front Oncol Yiming N, Saibaidoula Y, Abulimiti K, Ou J. PMID: 42851301 [PubMed]

Articles 1 - 20 / 222898

Page 1 of 11145



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy